Carbenoxolone (International)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
A02BX01
CAS registry number (Chemical Abstracts Service)
0005697-56-3
Chemical Formula
C34-H50-O7
Molecular Weight
571
Therapeutic Categories
Treatment of peptic ulcer
Topical treatment of mouth ulcer
Chemical Name
Olean-12-en-29-oic acid, 3-(3-carboxy-1-oxopropoxy)-11-oxo-, (3β,20β)-
Foreign Names
- Carbenoxolonum (Latin)
- Carbenoxolon (German)
- Carbénoxolone (French)
- Carbenoxolona (Spanish)
Generic Names
- Carbenoxolone (OS: BAN)
- Enoxolone succinate (IS)
- Carbenoxolone Sodium (OS: BANM, USAN, JAN)
- Disodium succinoyl glycyrrhetinate (INCI) (IS)
- Carbenoxolone Sodium (PH: BP 2016)
Brand Names
- Carbosan
Rowa, Hungary - Herpesan
Rowa, Peru - Carbelone
Royal, Taiwan - Carbosan
Rowa, Lithuania; Rowa, Malta; Rowa Pharmaceuticals, Kuwait - Carbosan 2%
Rowa, Oman - Carboxe
Shiteh Organic, Taiwan - Copu
Winston, Taiwan - Herpesan
Rowa, Dominican Republic; Rowa, Guatemala; Rowa, Hong Kong; Rowa, Malaysia; Rowa, Nicaragua; Rowa, Panama; Rowa, Paraguay; Rowa, El Salvador - Rowagel
Rowa, Philippines - Sanodin
ERN, Spain
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
